ROBERT NELSEN Insider Trading
Get free email notifications about insider trading for ROBERT NELSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT NELSEN. ROBERT NELSEN is a in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and a Director in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in Unity Biotechnology, Inc. ($UBX) and a Director in Syros Pharmaceuticals, Inc. ($SYRS) and a Director in Juno Therapeutics, Inc. ($JUNO) and a Director in Bellerophon Therapeutics, Inc. ($BLPH) and a Director in Sage Therapeutics, Inc. ($SAGE) and a in Sienna Biopharmaceuticals, Inc. ($SNNA) and a Director in Sienna Biopharmaceuticals, Inc. ($SNNA) and a Director in Denali Therapeutics Inc. ($DNLI) and a Director in Vir Biotechnology, Inc. ($VIR) and a Director in Beam Therapeutics Inc. ($BEAM) and a in Karuna Therapeutics, Inc. ($KRTX) and a Director in Karuna Therapeutics, Inc. ($KRTX) and a Director in Lyell Immunopharma, Inc. ($LYEL) and a Director in Sana Biotechnology, Inc. ($SANA).
Companies in which ROBERT NELSEN is an Insider
AGIOS PHARMACEUTICALS, INC.
Trading Symbol: AGIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 9,174 shares
Current Value: $407,509
Latest Transaction: Mar 07 2017
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Beam Therapeutics Inc.
Trading Symbol: BEAMIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 3,521,520 shares
Latest Transaction: Apr 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Bellerophon Therapeutics, Inc.
Trading Symbol: BLPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 965,660 shares
Current Value: $637,336
Latest Transaction: Feb 23 2015
$BLPH Market Capitalization: $9.84M
$BLPH Previous Close: $0.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Denali Therapeutics Inc.
Trading Symbol: DNLIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 10,668,749 shares
Latest Transaction: Jun 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Juno Therapeutics, Inc.
Trading Symbol: JUNOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 3,234 shares
Current Value: $67,138
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Karuna Therapeutics, Inc.
Trading Symbol: KRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 1,456,437 shares
Latest Transaction: Apr 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KYTHERA BIOPHARMACEUTICALS INC
Trading Symbol: KYTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN:
Holdings: 10,295 shares
Latest Transaction: Mar 26 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lyell Immunopharma, Inc.
Trading Symbol: LYELIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 18,206,358 shares
Latest Transaction: Jun 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sage Therapeutics, Inc.
Trading Symbol: SAGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 107,950 shares
Current Value: $5,149,215
Latest Transaction: Nov 12 2015
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sana Biotechnology, Inc.
Trading Symbol: SANAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 12,500 shares
Latest Transaction: Apr 27 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sienna Biopharmaceuticals, Inc.
Trading Symbol: SNNAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN:
Holdings: 2,538,641 shares
Latest Transaction: Jun 05 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Trading Symbol: SYRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 479,999 shares
Current Value: $5,241,589
Latest Transaction: Jun 12 2017
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Unity Biotechnology, Inc.
Trading Symbol: UBXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 2,070,172 shares
Latest Transaction: Jun 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vir Biotechnology, Inc.
Trading Symbol: VIRIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 11,832,766 shares
Latest Transaction: Apr 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT NELSEN
Sentiment: All, AGIO, BEAM, BLPH, DNLI, JUNO, KRTX, KYTH, LYEL, SAGE, SANA, SNNA, SYRS, UBX, VIR
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 435,142 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 435,142 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 17,771,216 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 17,771,216 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 18,206,358 | 0 | 18,206,358 | 0 to 18.2 M |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 18,206,358 | 0 | 18,206,358 | 0 to 18.2 M |
Apr 27 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |